Pathological remodeling of distal lung matrix in end-stage cystic fibrosis patients

被引:6
|
作者
Pinezich, Meghan R. [1 ]
Tamargo, Manuel A. [1 ,2 ]
Fleischer, Sharon [1 ]
Reimer, Jonathan A. [1 ,3 ]
Hudock, Maria R. [1 ]
Hozain, Ahmed E. [1 ,3 ]
Kaslow, Sarah R. [1 ,3 ]
Tipograf, Yuliya [5 ]
Soni, Rajesh Kumar [4 ]
Gavaudan, Olimpia P. [1 ]
Guenthart, Brandon A. [7 ]
Marboe, Charles C. [8 ]
Bacchetta, Matthew [5 ,6 ]
O'Neill, John D. [9 ]
Dorrello, N. Valerio [10 ]
Vunjak-Novakovic, Gordana [1 ,2 ,11 ]
机构
[1] Columbia Univ, Dept Biomed Engn, New York, NY 10032 USA
[2] Columbia Univ, Irving Med Ctr, Dept Med, New York, NY USA
[3] Columbia Univ, Irving Med Ctr, Dept Surg, New York, NY USA
[4] Columbia Univ, Irving Med Ctr, Herbert Irving Comprehens Canc Ctr, Prote & Macromol Crystallog Shared Resource, New York, NY USA
[5] Vanderbilt Univ, Med Ctr, Dept Thorac Surg, Nashville, TN USA
[6] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA
[7] Stanford Univ, Dept Cardiothorac Surg, Stanford, CA 94305 USA
[8] Columbia Univ, Irving Med Ctr, Dept Pathol & Cell Biol, New York, NY USA
[9] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA
[10] Columbia Univ, Irving Med Ctr, Dept Pediat, New York, NY USA
[11] Columbia Univ, Irving Med Ctr, Coll Dent Med, New York, NY USA
关键词
Cystic fibrosis; Extracellular matrix; Lung proteases; Basement membrane; Biomarkers; SPUTUM; METALLOPROTEINASES; CHILDREN; AIRWAY; INFLAMMATION; DESTRUCTION; COLLAGENASE; BIOMARKERS; IMBALANCE; ELASTIN;
D O I
10.1016/j.jcf.2022.04.016
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Manifestations of cystic fibrosis, although well-characterized in the proximal airways, are understudied in the distal lung. Characterization of the cystic fibrosis lung "matrisome" (matrix proteome) has not been previously described, and could help identify biomarkers and inform therapeutic strategies. Methods: We performed liquid chromatography-mass spectrometry, gene ontology analysis, and multi-modal imaging, including histology, immunofluorescence, and electron microscopy for a comprehensive evaluation of distal human lung extracellular matrix (matrix) structure and composition in end-stage cystic fibrosis. Results: Quantitative proteomic profiling identified sixty-eight (68) matrix constituents with significantly altered expression in end-stage cystic fibrosis. Over 90% of significantly different matrix peptides detected, including structural and basement membrane proteins, were expressed at lower levels in cystic fibrosis. However, the total abundance of matrix in cystic fibrosis lungs was not significantly different from control lungs, suggesting that cystic fibrosis leads to loss of diversity among lung matrix proteins rather than an absolute loss of matrix. Visualization of distal lung matrix via immunofluorescence and electron microscopy revealed pathological remodeling of distal lung tissue architecture and loss of alveolar basement membrane, consistent with significantly altered pathways identified by gene ontology analysis. Conclusions: Dysregulation of matrix organization and aberrant wound healing pathways are associated with loss of matrix protein diversity and obliteration of distal lung tissue structure in end-stage cystic fibrosis. While many therapeutics aim to functionally restore defective cystic fibrosis transmembrane conductance regulator (CFTR), drugs that target dysregulated matrix pathways may serve as adjunct interventions to support lung recovery. (c) 2022 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1027 / 1035
页数:9
相关论文
共 50 条
  • [31] The use of rocuronium in a patient with cystic fibrosis and end-stage lung disease made safe by sugammadex reversal
    Porter, M. V.
    Paleologos, M. S.
    ANAESTHESIA AND INTENSIVE CARE, 2011, 39 (02) : 299 - 302
  • [32] Bone involvement in young adults with cystic fibrosis awaiting lung transplantation for end-stage respiratory failure
    E. Cairoli
    C. Eller-Vainicher
    L.C. Morlacchi
    P. Tarsia
    V. Rossetti
    M. Pappalettera
    M. Arosio
    I. Chiodini
    F. Blasi
    Osteoporosis International, 2019, 30 : 1255 - 1263
  • [33] COMBINED PANCREATIC ISLET-LUNG TRANSPLANTATION: A NOVEL APPROACH TO THE TREATMENT OF END-STAGE CYSTIC FIBROSIS
    Baltzinger, Philippe
    Bahougne, Thibault
    Greget, Michel
    Degot, Tristan
    Reeb, Jeremie
    Bonnette, Pierre
    Gut, A.
    Grenet, Dominique
    Bouilloud, F.
    Berney, Thierry
    Stern, Marc
    Kessler, Romain
    Massard, Gilbert
    Kessler, Laurence
    TRANSPLANT INTERNATIONAL, 2015, 28 : 10 - 10
  • [34] COMBINED PANCREATIC ISLET-LUNG TRANSPLANTATION: A NOVEL APPROACH TO THE TREATMENT OF END-STAGE CYSTIC FIBROSIS
    Baltzinger, P.
    Bahougne, T.
    Kessler, L.
    Gegot, T.
    Greget, M.
    TRANSPLANT INTERNATIONAL, 2015, 28 : 4 - 4
  • [35] Combined Pancreatic Islet-Lung Transplantation: A Novel Approach to the Treatment of End-Stage Cystic Fibrosis
    Kessler, L.
    Bakopoulou, S.
    Kessler, R.
    Massard, G.
    Santelmo, N.
    Greget, M.
    Moreau, F.
    Helms, O.
    Bosco, D.
    Gasche-Soccal, P.
    Morel, P.
    Wolf, P.
    Berney, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (07) : 1707 - 1712
  • [36] High-Frequency Percussive Ventilation in an Intubated Child with Cystic Fibrosis and End-Stage Lung Disease
    Johnson, Z. J.
    Dowell, M. L.
    Palla, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [37] Model for end-stage liver disease (MELD) exception for cystic fibrosis
    Horslen, Simon
    Sweet, Stuart
    Gish, Robert G.
    Shepherd, Ross
    LIVER TRANSPLANTATION, 2006, 12 (12) : S98 - S99
  • [38] Bone involvement in young adults with cystic fibrosis awaiting lung transplantation for end-stage respiratory failure
    Cairoli, E.
    Eller-Vainicher, C.
    Morlacchi, L. C.
    Tarsia, P.
    Rossetti, V.
    Pappalettera, M.
    Arosio, M.
    Chiodini, I.
    Blasi, F.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 (06) : 1255 - 1263
  • [39] Prevalence of pulmonary hypertension in end-stage cystic fibrosis and correlation with survival
    Tonelli, Adriano R.
    Fernandez-Bussy, Sebastian
    Lodhi, Saba
    Akindipe, Olufemi A.
    Carrie, Robin D.
    Hamilton, Karen
    Mubarak, Kamal
    Baz, Maher A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (08): : 865 - 872
  • [40] HEART-LUNG TRANSPLANTATION FOR END-STAGE RESPIRATORY-DISEASE IN PATIENTS WITH CYSTIC-FIBROSIS AT PAPWORTH-HOSPITAL
    DENNIS, C
    CAINE, N
    SHARPLES, L
    SMYTH, R
    HIGENBOTTAM, T
    STEWART, S
    WREGHITT, T
    LARGE, S
    WELLS, FC
    WALLWORK, J
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1993, 12 (06): : 893 - 902